In This UCI Mind Alzheimer’s Article:
Helping People with Alzheimer’s Disease Maintain Mental Function
Managing Behavioral Symptoms
Slowing, Delaying or Preventing Alzheimer’s Disease
The U.S. Food and Drug Administration (FDA) has approved four medications to treat Alzheimer’s disease. Donepezil (Aricept*), rivastigmine, (Exelon*), and galantamine (Razadyne*) are approved to treat mild to moderate Alzheimer’s. (donepezil can be used for severe cases as well). Memantine (Namenda*) is approved to treat moderate to severe Alzheimer’s disease. They work by regulating the chemicals that transmit messages between neurons, the neurotransmitters. In many cases they work on thinking, memory and speaking skills and may help with certain behavioral problems. The effects do not last, because these drugs do not change the underlying disease process, which continues. Their effectiveness may last for only a few months or a few years.
Sleeplessness, agitation, wandering, anxiety, anger and depression are common behavioral symptoms of Alzheimer’s disease. Not every patient experiences them, however. There are many other behaviors that patients may exhibit such as changes in personality or paranoia. Scientists are learning why these behaviors occur, as they research new treatments, both drug and non-drug, to better manage them. This research will allow people with Alzheimer’s disease to live more comfortable lives and their make their care easier for caregivers
Scientists today are looking beyond treating the symptoms of the disease and are focusing on addressing the underlying disease process. They are looking at clinical trials for many possible interventions, such as immunization therapy, cardiovascular treatments, antioxidants, cognitive training and physical activity.
Have questions about Alzheimer’s Disease? Connect with our Alzheimer’s Disease Expert and Alzheimer’s Research Expert Now!
Related Links:
Alzheimer’s Articles by UCI Mind:
More Articles About Alzheimer’s Disease:
Other SeniorCareHomes.com Helpful Links:
Copyright 2019 SeniorCareHomes.Com. All Rights Reserved.
Catharine “Kate” is a Certified Administrator for Residential Care Facilities for the Elderly (RCFE) and an Expert Senior Care Advisor. Kate’s grandmother battled Alzheimer’s Disease and Kate personally understands what millions of families are going through. Kate and her team are very passionate in empowering Seniors and their families by providing them with the Best Available Senior Care Options based on Senior’s care needs, preferred location and family’s budget.
One of the Leading Operators of Senior Living Communities in the U.S. (Click…
My elderly father is now 90 years old, and my mother is just three years…
The "Next Level" Medical Alert System FACT: The CDC (Centers for Disease Control and Prevention) states…
Alzheimer's Disease Frequently Asked Questions with Dr. Fortanasce, Neurologist / Alzheimer's Expert Why is Alzheimer’s such a huge…
Assisted living costs are getting more and more expensive. In fact, the average annual…
Residential Care Home vs Assisted Living Community Being in the Senior Care Industry for…